Our Services
Others
- DFPP
- Shockwave
- IV Drip
Stem cell therapy is increasingly recognized as a revolutionary method for treating diabetes, especially type 1 diabetes. This condition arises when the body’s immune system erroneously targets and destroys the insulin-producing beta cells within the pancreas. While existing treatments, such…
Diabetic foot ulcers (DFUs) represent a severe and long-lasting complication commonly linked to diabetes. These wounds often resist healing and can persist for extended periods, leading to significant health issues including infections and even amputations. Standard treatment options like wound…
Stem cell therapy has emerged as an innovative and minimally invasive treatment option for various shoulder injuries and degenerative conditions. The shoulder, being one of the body’s most flexible and frequently used joints, is particularly prone to damage and wear…
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder characterized by peripheral insulin resistance paired with the gradual failure of pancreatic . Current management strategies primarily biguanides, SGLT2 inhibitors, and exogenous insulin analogs excel at symptomatic glucose stabilization but fail…
Type 2 diabetes mellitus (T2DM) presents a mounting global health issue, affecting over 400 million individuals worldwide. Characterized by insulin resistance and pancreatic beta-cell dysfunction, T2DM often leads to chronic complications, including cardiovascular disease, neuropathy, nephropathy, and impaired wound healing.…
An ulcer that won’t close after three months isn’t just slow to heal it’s telling you something has broken down in the body’s repair process. Chronic ulcer wounds show up most often in the legs, feet, and toes, and they’re…
Diabetic foot ulcers, particularly those affecting the toes, are a common and serious complication of diabetes mellitus. These ulcers develop due to a combination of issues such as reduced blood flow, nerve impairment (neuropathy), and a weakened immune system. If…
Diabetic foot ulcers (DFUs) represent a significant complication of diabetes mellitus, often leading to chronic wounds, infections, and, in severe cases, amputations. Traditional treatments, including infection control, surgical debridement, and revascularization, have limitations, particularly in patients with poor circulation and…
Stem cell therapy is rapidly gaining recognition as a promising strategy in the treatment of diabetes due to its unique regenerative abilities and its potential to directly address the underlying causes of the disease. Both type 1 and type 2…
Stem cell therapy has emerged as a transformative tool in modern medicine, particularly for its ability to accelerate wound healing and minimize scarring. Due to their exceptional regenerative properties, stem cells are being explored as a potential solution for both…
Diabetic foot ulcers (DFUs) are among the most prevalent and debilitating complications in individuals with diabetes mellitus. Affecting approximately 15–25% of patients during their lifetime, DFUs represent a leading cause of hospitalization and lower extremity amputation globally. Conventional treatments often…
In the population with diabetes mellitus, diabetic heel ulcers are a serious medical concern. These chronic wounds, which are seen in the posterior plantar region, are commonly linked to pressure-induced trauma, ischaemia, and peripheral neuropathy. About 15% of diabetics will…
Chronic ulcers, which include pressure sores, venous leg ulcers, and ischaemic wounds, pose a substantial public health concern due to their lengthy healing duration and high recurrence rates. These lesions frequently afflict people who have comorbidities such vascular insufficiency, extended…
Stem cell therapy is an emerging and promising medical technique that harnesses the regenerative potential of stem cells to repair injured eye tissue, potentially improving or restoring vision. A variety of ocular diseases, including macular degeneration, diabetic retinopathy, glaucoma, retinal…
Bangkok, Thailand – June 5, 2025 Vega Stem Cell is pleased to announce its appointment as one of the first official distributors of “Please,” a newly FDA-approved oral Sildenafil medication in Thailand, distributed by DKSH—a global leader in healthcare logistics.…
Chronic foot ulcers are a common and debilitating consequence of diabetes, particularly type 2. These lesions affect up to 25% of diabetes individuals and are a primary cause of lower-limb amputations worldwide. Because of the complex nature of diabetic wounds,…
UC-MSC Stem Cell Therapy for Chronic Ulcers: Regenerative Support for Difficult-to-Heal Wounds Chronic ulcers are not ordinary skin wounds. They are persistent tissue defects that fail to progress through the normal stages of healing because the local wound environment has…
Diabetic ulcers, especially those occurring on the feet, are among the most frequent and serious complications of diabetes. These chronic wounds affect nearly one in four diabetic patients during their lifetime and are a primary cause of lower-limb amputations. Despite…
Stem cell therapy is emerging as a modern, non-invasive treatment option for people with hip dysplasia. This approach is particularly appealing for patients who seek to avoid surgery and are looking for natural ways to repair damaged tissues and manage…
Stem cell therapy is emerging as a cutting-edge solution for treating chronic back pain by utilizing the body’s innate capacity to heal itself. This innovative treatment aims to repair or regenerate damaged spinal tissues, such as intervertebral discs, ligaments, cartilage,…